Oncology

The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.

Latest News

Topical Drug Delivery May Offer Welcome Alternatives for Breast Cancer Treatment
Topical Drug Delivery May Offer Welcome Alternatives for Breast Cancer Treatment

February 3rd 2025

Topical, targeted drug delivery increases drug concentrations at the desired site while also reducing toxicity and unwanted adverse effects.

Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025

February 3rd 2025

HER2-ultralow now refers to patients who have low levels of HER2 expression, is lower than the existing HER2-low category. | Image Credit: Saiful52 | stock.adobe.com
FDA Approves Diagnostic Label Expansion for HR+, HER2–Ultra-Low Metastatic Breast Cancer

February 1st 2025

Breast cancer cell | Image Credit: @ Sara_P - stock.adobe.com
Ribociclib Plus Adjuvant Endocrine Therapy Is Safe, Tolerable in Patients With HR+/HER2– Breast Cancer

January 31st 2025

3D illustration Virus DNA molecule, structure. Concept destroyed code human genome. Damage DNA molecule. Helix consisting particle, dots. DNA destruction due to gene mutation or experiment
Calreticulin Mutations Can Worsen Survival Outcomes in Ruxolitinib-Treated Patients With Myelofibrosis

January 31st 2025

<1
...
227228229230231